智通财经APP获悉，雅各臣科研制药(02633)涨近6%，近半年来该股股价累涨超六成。截至发稿，涨5.83%，报1.09港元，成交额1400.06万港元。
消息面上，雅各臣科研制药此前发布截至2024年9月30日止6个月的中期业绩，该集团来自持续经营业务的收益约为8.1亿港元，同比增加13.3%；来自持续经营业务的溢利约为1.403亿港元，同比增加44.2%；每股盈利7.07港仙，拟派发中期股息每股3.5港仙。
公司指，期内来自持续经营业务的溢利大幅增长，主要由于非专利药业务于公、私营界别均表现强劲，以及新引进授权产品及成功推出新产品所带来的收益贡献。此外，公司提高生产设施的营运杠杆，以及因成本控制措施行之有效而减省了财务费用，均有助增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.